Thrombolytic Effects of the Snake Venom Disintegrin Saxatilin Determined by Novel Assessment Methods: A FeCl3-Induced Thrombosis Model in Mice

Plasminogen Activation and Thrombolysis for Ischemic Stroke

(2012) Robert L. Medcalf et al.   International Journal of Stroke

Mechanisms underlying FeCl3-induced arterial thrombosis

(2011) A. ECKLY et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

(2010) Kennedy R Lees et al.   LANCET

Thrombolysis With Plasmin: Implications for Stroke Treatment

(2010) V. J. Marder et al.   STROKE

The molecular basis of thrombolysis and its clinical application in stroke

(2009) V. Murray et al.   JOURNAL OF INTERNAL MEDICINE

Randomized, Placebo-Controlled, Dose-Ranging Clinical Trial of Intravenous Microplasmin in Patients With Acute Ischemic Stroke

(2009) Vincent N.S. Thijs et al.   STROKE

Ultrastructural and temporal changes of the microvascular basement membrane and astrocyte interface following focal cerebral ischemia

(2008) Il Kwon et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study

(2008) Werner Hacke et al.   LANCET NEUROLOGY

Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

(2008) Werner Hacke et al.   NEW ENGLAND JOURNAL OF MEDICINE

Acute and repeated dose toxicity studies of recombinant saxatilin, a disintegrin from the Korean snake (Gloydius saxatilis)

(2007) Young-Doug Sohn et al.   TOXICON